eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decline of 23.9% from the November 30th total of 35,200 shares. Based on an average daily volume of 16,000 shares, the short-interest ratio is presently 1.7 days.

eFFECTOR Therapeutics Price Performance

EFTRW remained flat at $0.16 during midday trading on Monday. eFFECTOR Therapeutics has a 1-year low of $0.04 and a 1-year high of $0.99. The stock has a fifty day moving average of $0.13 and a 200 day moving average of $0.17.

Recommended Stories

• Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
• MarketBeat: Week in Review 12/26 – 12/30
• The Dogs Of Tech: It's Time For A Bite Of These Stocks
• Does This Acquisition Make Microsoft a Bear Market Buy?
• Should You Warm up to Generac Stock for the Winter?
• Is Kintara Therapeutics A Hidden Gem?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.